Tag: Henry Adewoye

Compugen kickstarts phase 1 trial of cancer immunotherapy COM701

pharmanewsdaily- September 8, 2018

Israeli pharma company Compugen has dosed the first patient in the phase 1 clinical trial which is evaluating the company’s cancer immunotherapy antibody COM701 in ... Read More